These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19777418)

  • 1. [Risk prediction using cardiovascular magnetic resonance imaging].
    Yilmaz A; Sechtem U
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2008-12. PubMed ID: 19777418
    [No Abstract]   [Full Text] [Related]  

  • 2. Dobutamine stress magnetic resonance imaging.
    Rerkpattanapipat P; Hundley WG
    Echocardiography; 2007 Mar; 24(3):309-15. PubMed ID: 17313648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current clinical applications of stress wall motion analysis with cardiac magnetic resonance imaging.
    Paetsch I; Jahnke C; Fleck E; Nagel E
    Eur J Echocardiogr; 2005 Oct; 6(5):317-26. PubMed ID: 16112912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of dobutamine stress cardiovascular magnetic resonance imaging in children.
    Strigl S; Beroukhim R; Valente AM; Annese D; Harrington JS; Geva T; Powell AJ
    J Magn Reson Imaging; 2009 Feb; 29(2):313-9. PubMed ID: 19161182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging.
    Kelle S; Roes SD; Klein C; Kokocinski T; de Roos A; Fleck E; Bax JJ; Nagel E
    J Am Coll Cardiol; 2009 Nov; 54(19):1770-7. PubMed ID: 19874990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations of the French Society of Cardiology concerning the practice of ischemia provocation tests in adult nuclear cardiology].
    Furber A; Berdagué P; Cadiou C; David N; Faraggi M; Fourquet N; Hélias J; Le Guludec D; Marie PY; Ouhayoun E; Pézard P; Vanzetto G; Weinmann P;
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11):1309-32. PubMed ID: 11190460
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk stratification with electrocardiographic-gated dobutamine stress imaging.
    Elhendy A; Schinkel AF; Bax JJ; Poldermans D
    J Am Coll Cardiol; 2006 Oct; 48(7):1472; author reply 1472-3. PubMed ID: 17010815
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular MRI: what cardiologists need to know.
    Agarwal R; Sola S
    Indian Heart J; 2007; 59(1):69-76. PubMed ID: 19098339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The demystification of magnetic resonance imaging?
    Hoffmann R
    Eur Heart J; 2006 Jun; 27(12):1394-5. PubMed ID: 16720690
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac magnetic resonance imaging.
    Cury RC
    Top Magn Reson Imaging; 2008 Feb; 19(1):1-2. PubMed ID: 18690155
    [No Abstract]   [Full Text] [Related]  

  • 11. An unusual cause of susceptibility artifact in magnetic resonance imaging.
    Cook SC; Shull J; Pickworth-Pierce K; Farra Y; Simonetti OP; Raman SV
    J Magn Reson Imaging; 2006 Nov; 24(5):1148-50. PubMed ID: 17036360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac magnetic resonance imaging: techniques and clinical applications.
    Turkbey EB; Dombroski DA
    Semin Roentgenol; 2009 Apr; 44(2):67-83. PubMed ID: 19233083
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical use of cardiovascular magnetic resonance.
    Pohost GM; Hung L; Doyle M
    Circulation; 2003 Aug; 108(6):647-53. PubMed ID: 12912794
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monitoring of cardiovascular risk factors in patients with diabetes type 2].
    Petrlová B; Rosolová H; Simon J; Sefrna F; Sifalda P; Sípová I
    Vnitr Lek; 2009 Sep; 55(9):812-8. PubMed ID: 19785382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Magnetic resonance angiography and spectroscopy in cardiovascular disease].
    Nakano T; Konishi T; Okamoto S; Sakuma H; Takeda K
    Kokyu To Junkan; 1991 Nov; 39(11):1081-4. PubMed ID: 1775737
    [No Abstract]   [Full Text] [Related]  

  • 16. Nuclear magnetic resonance of the cardiovascular system: our experience in 112 subjects.
    Gaudio C; Reale A
    Cardiologia; 1988 Oct; 33(10):907-16. PubMed ID: 3233600
    [No Abstract]   [Full Text] [Related]  

  • 17. The prognostic implications of cardiovascular magnetic resonance.
    Flett AS; Westwood MA; Davies LC; Mathur A; Moon JC
    Circ Cardiovasc Imaging; 2009 May; 2(3):243-50. PubMed ID: 19808599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacologic tests in cardiac decompensation].
    Perini G; Pozzoli M
    G Ital Cardiol; 1995 Dec; 25(12):1635-41. PubMed ID: 8707012
    [No Abstract]   [Full Text] [Related]  

  • 19. [Magnetic resonance in the assessment of cardiovascular diseases].
    Buser PT
    Schweiz Rundsch Med Prax; 1989 Feb; 78(9):211-3. PubMed ID: 2928617
    [No Abstract]   [Full Text] [Related]  

  • 20. Additional value of myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease.
    Gebker R; Jahnke C; Manka R; Hamdan A; Schnackenburg B; Fleck E; Paetsch I
    Circ Cardiovasc Imaging; 2008 Sep; 1(2):122-30. PubMed ID: 19808529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.